Sim&Cure Inc

Sim&Cure is a medical technology company specializing in next-generation brain aneurysm treatment solutions for endovascular procedures. The company develops digital twin and AI-powered software platforms designed to support physicians in neurovascular care. Their flagship product, Sim&Size, is a surgical planning and procedural support system that leverages patient-specific computational modeling to enhance procedural planning and execution for aneurysm treatment. The platform integrates with major medical imaging and device systems from partners including Siemens, Philips, Medtronic, Stryker, MicroVention-Terumo, and others. Sim&Cure's solutions are deployed across multiple continents, serving hospitals and healthcare professionals globally. The company operates through regional product life cycle teams covering EMEA, APAC, and Americas markets. Their regulatory and quality assurance infrastructure is led by senior leadership with expertise in medical device compliance. Sim&Cure has secured significant funding (€10M Series extension as of late 2025) to advance its neurovascular procedure platform. The company positions itself as a research and innovation leader in aneurysm care, collaborating with healthcare systems to improve procedural success rates and patient outcomes through intelligent, data-driven decision support.